Table 2.
Male (n=32) (60.3%) | Female (n=21) (39.6%) | |
---|---|---|
Age | 77.3±5.6 | 74.2±3.1 |
Altered mental status | 26 (81.2%) | 4 (19.04%) |
Nausea and vomiting | 14 (43.7%) | 7 (33.3%) |
Diarrhea | 11 (33.3%) | 6 (28.5%) |
Increased sweating | 8 (25%) | 2 (9.5%) |
Increased secretions | 11 (34.3%) | 1 (4.7%) |
Jaundice | 6 (18.7%) | 1 (4.7%) |
Pain abdomen | 5 (15.6%) | 2 (9.5%) |
Discharge from ed | 5 (15.6%) | 1 (4.7%) |
Intensive care unit | 12 (37.5%) | 2 (9.5%) |
History of substance abuse | 12 (37.5%) | 1 (4.7%) |
Lung disease | 13 (40.6%) | 1 (4.7%) |
Mortality | 7 (21.8%) | 2 (9.5%) |
Intentional exposure | 22 (68.7%) | 15 (71.4%) |
Unintentional exposure | 10 (31.2%) | 1 (4.7%) |
Depression/insomnia | 11 (34.3%) | 6 (18.7%) |
Respiratory distress | 14 (43.7%) | 3 (14.2%) |
Pneumonia | 12 (37.5%) | 2 (9.5%) |
Shock | 9 (42.8%) | 3 (14.2%) |
Acute lung injury | 6 (18.7%) | 1 (4.7%) |
Aspiration pneumonia | 10 (31.2%) | 2 (9.5%) |
Hypertension | 20 (61.5%) | 10 (31.2%) |
Diabetes mellitus | 12 (37.5%) | 6 (18.7%) |
Chronic kidney disease | 5 (15.6%) | 2 (9.5%) |